$MMSI

MERIT MEDICAL SYSTEMS INC

No enriched coverage for $MMSI in the last 7 days.

No SEC Form 4 filings for $MMSI in the last 30 days.

Med

Merit Medical Systems (NASDAQ:MMSI) Exceeds Q4 CY2025 Expectations

Merit Medical Systems (NASDAQ:MMSI) announced better-than-expected revenue for Q4 CY2025, with sales up 10.9% year-on-year to $393.9 million, surpassing analyst estimates. Both the full-year revenue guidance and adjusted EBITDA also beat expectations, although non-GAAP profit for the quarter slightly missed consensus estimates. The company showed strong operating margin improvement and impressive long-term EPS growth, despite a minor miss on quarterly adjusted EPS.

Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Consensus Recommendation of "Moderate Buy" by Analysts

Merit Medical Systems, Inc. (NASDAQ:MMSI) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $105.88. The company recently reported strong quarterly earnings and revenue, surpassing analyst estimates, and has set optimistic full-year 2025 guidance. Despite recent insider selling, institutional investors hold a significant portion of the stock.

Assenagon Asset Management S.A. Acquires Shares of 19,750 Merit Medical Systems, Inc. $MMSI

Assenagon Asset Management S.A. has acquired 19,750 shares of Merit Medical Systems, Inc. in the third quarter, valued at approximately $1.64 million, with institutional investors now holding 99.66% of the stock. Insider selling, specifically by Chairman Fred P. Lampropoulos, has amounted to 60,000 shares in the last 90 days. Merit Medical Systems surpassed Q3 earnings expectations, reporting a revenue increase of 13% year-over-year and forecasting FY2025 EPS between $3.66 and $3.79, while analysts maintain a "Moderate Buy" rating with an average price target of $105.88.